Association between Streptococcus and chronic obstructive pulmonary disease: A two-sample Mendelian randomization study
Authors:
Open Access
- 11 July 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (28) , e43306
Abstract
Streptococcus is one of the most common causative agents of acute exacerbations of chronic obstructive pulmonary disease (COPD). It may cause infection and inflammation in the lungs, leading to dyspnea and other symptoms. However, the causal connection between Streptococcus and COPD has not been elucidated. This study aimed to investigate the causal relationship between Streptococcus and the risk of COPD. Using a large-scale genome-wide association study database, a series of quality control steps were taken to select qualified single nucleotide polymorphisms that were strongly associated with exposure. Two-sample Mendelian randomization (MR) was used to evaluate the causal effect of Streptococcus on COPD, including inverse variance weighting, MR-Egger, weighted median, weighted mode, and simple mode. MR-Egger intercept tests, Cochran Q test, MR-PRESSO global test, and “leave-one-out” sensitivity analyzes were applied to assess horizontal pleiotropy, heterogeneity, and stability. Based on extensive genetic data obtained from genome-wide association studies involving 468,475 European participants, we included a total of 14 single nucleotide polymorphisms as instrumental variables. MR results confirmed an association between Streptococcus and a higher risk of COPD (odds ratio = 1.18, confidence interval = 1.01–1.38, P = 4.28 × 10-2). Analyses of heterogeneity (P > .05) and pleiotropy (P > .05) analysis confirmed the reliability of MR results. We verified the possibility of a causal link between Streptococcus and COPD, thereby highlighting the connection of the gut–lung axis.Keywords
Funding Information
- Nanjing Medical University Changzhou Medical Center Research Project (CMCC202416)
This publication has 42 references indexed in Scilit:
- The role of vitamin D in the prevention and treatment of tuberculosis: a meta-analysis of randomized controlled trialsInfection, 2024
- Association between Bariatric Surgery and Outcomes of Total Joint ArthroplastyOsteoarthritis and Cartilage, 2024
- The role of vitamin D in the prevention and treatment of SARS-CoV-2 infection: A meta-analysis of randomized controlled trialsClinical Nutrition, 2023
- Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A reviewBiomedicine & Pharmacotherapy, 2023
- The gut microbiome is a significant risk factor for future chronic lung diseaseJournal of Allergy and Clinical Immunology, 2022
- Prevalence of Pulmonary Diseases in Association with Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2022
- Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian RandomizationJAMA, 2021
- Human gut microbiome impacts skeletal muscle mass via gut microbial synthesis of the short‐chain fatty acid butyrate among healthy menopausal womenJournal of Cachexia, Sarcopenia and Muscle, 2021
- The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary diseaseJournal of Allergy and Clinical Immunology, 2021
- Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methodsStatistics in Medicine, 2015